← Back to Search

Procedure

Arm 1-Repeat Cryoballoon Ablation for Atrial Fibrillation

N/A
Waitlist Available
Led By Advay Bhatt, MD
Research Sponsored by Valley Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up six months
Awards & highlights

Study Summary

This trial will compare cryoballoon ablation to radiofrequency ablation in people who have had cryoballoon ablation before for atrial fibrillation and now have it again.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six months
This trial's timeline: 3 weeks for screening, Varies for treatment, and six months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
PrimaryCryoballoon vs. Rhythmia Guided Ablation for Recurrent AFib

Trial Design

2Treatment groups
Experimental Treatment
Group I: Arm 2-Radiofrequency AblationExperimental Treatment1 Intervention
Participants will have radiofrequency ablation guided by high-fidelity mapping (Rhythmia) following an initial cryoballoon ablation.
Group II: Arm 1-Repeat Cryoballoon AblationExperimental Treatment1 Intervention
Subjects will be randomized to repeat cryoballoon ablation.

Find a Location

Who is running the clinical trial?

Valley Health SystemLead Sponsor
9 Previous Clinical Trials
1,843 Total Patients Enrolled
4 Trials studying Atrial Fibrillation
565 Patients Enrolled for Atrial Fibrillation
Advay Bhatt, MDPrincipal InvestigatorThe Valley Hosptial

Media Library

Cryoballoon ablation (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT03811795 — N/A
Atrial Fibrillation Research Study Groups: Arm 1-Repeat Cryoballoon Ablation, Arm 2-Radiofrequency Ablation
Atrial Fibrillation Clinical Trial 2023: Cryoballoon ablation Highlights & Side Effects. Trial Name: NCT03811795 — N/A
Cryoballoon ablation (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03811795 — N/A
~8 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top